Methacholine challenge test by wheezing and oxygen saturation in preschool children with asthma

Allergologia et Immunopathologia (Impact Factor: 1.74). 06/2014; 43(2). DOI: 10.1016/j.aller.2014.02.005
Source: PubMed


Methacholine challenge test (MCT) performed with spirometry is a commonly used test to evaluate bronchial hyperreactivity (BHR) in children. However, preschoolers do not usually collaborate. Objectives: To assess the usefulness of MCT through clinical evaluation (wheezing auscultation and decreased pulse arterial oxygen saturation [SpO2]) in recurrent wheezing preschoolers with asthma, in comparison to healthy controls. Methods: We performed the MCT (modified Cockroft method) on healthy and on asthmatic preschoolers. The end point was determined by the presence of wheezing in the chest and/or tracheal auscultation (PCw) and/or a decrease in SpO2 of ≥5 from the baseline value (PCSpO2). Maximal methacholine concentration was 8. mg/ml. Results: The study population comprised 65 children: 32 healthy and 33 asthmatic children. There were no differences in demographic characteristics between the groups. The median methacholine doses for PCw and for PCSpO2 were significantly lower among asthmatic than healthy children: 0.5. mg/ml (0.25-0.5. mg/ml) vs. 2. mg/ml (1-4. mg/ml), respectively, p<. 0.001; and 0.25. mg/ml (0.25-0.5. mg/ml) and 2. mg/ml (0.5-4. mg/ml), respectively, p<. 0.001. The best cut-off point of PCw was observed at a methacholine concentration of 0.5. mg/ml (AUC. =. 0.72 [95% CI. =. 0.66-0.77]), its sensitivity was 91%, specificity 43%, PPV 16% and NPV 98%. For PCSpO2 the best cut-off point was a methacholine concentration of 1. mg/ml (AUC. =. 0.85 [95% CI 0.81-0.89]), with sensitivity of 80%, specificity 74%, PPV 49%, and NPV 92%. There were no adverse reactions. Conclusion: MCT using clinical parameters such as wheezing auscultation and SpO2 measurement could be a useful and safe test to confirm BHR among preschoolers.

Download full-text


Available from: Jose A Castro-Rodriguez, Dec 09, 2014
37 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Data for trends in prevalence of asthma, allergic rhinoconjunctivitis, and eczema over time are scarce. We repeated the International Study of Asthma and Allergies in Childhood (ISAAC) at least 5 years after Phase One, to examine changes in the prevalence of symptoms of these disorders. For the ISAAC Phase Three study, between 2002 and 2003, we did a cross-sectional questionnaire survey of 193,404 children aged 6-7 years from 66 centres in 37 countries, and 304,679 children aged 13-14 years from 106 centres in 56 countries, chosen from a random sample of schools in a defined geographical area. Phase Three was completed a mean of 7 years after Phase One. Most centres showed a change in prevalence of 1 or more SE for at least one disorder, with increases being twice as common as decreases, and increases being more common in the 6-7 year age-group than in the 13-14 year age-group, and at most levels of mean prevalence. An exception was asthma symptoms in the older age-group, in which decreases were more common at high prevalence. For both age-groups, more centres showed increases in all three disorders more often than showing decreases, but most centres had mixed changes. The rise in prevalence of symptoms in many centres is concerning, but the absence of increases in prevalence of asthma symptoms for centres with existing high prevalence in the older age-group is reassuring. The divergent trends in prevalence of symptoms of allergic diseases form the basis for further research into the causes of such disorders.
    The Lancet 09/2006; 368(9537):733-43. DOI:10.1016/S0140-6736(06)69283-0 · 45.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Asthma is a common disease in young children and is associated with significant morbidity and an increasing prevalence over time. Early childhood wheezing and asthma are heterogeneous disorders; thus identifying phenotypes of asthma remains a goal to identify high-risk children who might benefit from specific therapies or secondary prevention interventions. The typical pattern of illness in preschool-aged children consists of short but recurrent exacerbations of cough and wheeze usually triggered by viral respiratory tract infections. Documenting reversible airflow obstruction on lung function, allergen sensitization, increased IgE levels, or blood eosinophilia is helpful in establishing a diagnosis of asthma in preschool-aged children, if present; however, the diagnosis is most often based on symptom patterns, presence of risk factors, and therapeutic responses. The preschool-aged asthmatic population tends to be characterized as exacerbation prone with relatively limited impairment, unlike older children and adolescents who have more impairment-dominant disease. However, management of persistent disease is based largely on expert opinion and extrapolation from studies in older children given the relative lack of data in this age group. Strategies used to manage intermittent disease include daily and intermittent controller therapy. Management strategies for persistent asthma include daily inhaled corticosteroids, daily leukotriene receptor antagonists, and combination therapies. Finally, regular monitoring of symptom control and medication side effects is important along with titrating controllers to the minimally effective dose.
    The Journal of allergy and clinical immunology 06/2012; 130(2):287-96; quiz 297-8. DOI:10.1016/j.jaci.2012.04.025 · 11.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cough and wheeze are common symptoms in childhood, but mostly do not signify a serious illness. On the basis of history and examination, such children should be allocated into one of five diagnostic categories. Very few need additional tests, although there are specific pointers in the initial evaluation which should actively be sought, and result in referral for investigation. In a community setting, isolated cough with no wheeze or breathlessness is most unlikely to be due to asthma. In pre-school children who cannot perform lung function tests, a therapeutic trial of asthma treatment may be indicated, but a three step protocol is mandatory, stopping therapy if there appears to be a response, and only restarting if symptoms recur. In older children, documentation of variable airflow obstruction before giving a diagnosis of asthma is important, to avoid overdiagnosis. Prophylactic therapy on a long term basis with inhaled steroids in pre-school children does not reduce the likelihood of progression to asthma in mid-childhood, and the results of treatment in terms of symptoms are disappointing.
    Primary Care Respiratory Journal 03/2007; 16(1):7-15. DOI:10.3132/pcrj.2007.00001 · 2.50 Impact Factor
Show more